JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 11.80
+0.55 (4.89%)
At close: Nov 6, 2026
JFL Life Sciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,996 | 1,314 | 820.42 | 465.48 | 428.3 | 335.9 |
Other Revenue | 0.1 | 0.04 | - | 4.72 | 13.8 | 7.2 |
| 1,996 | 1,314 | 820.42 | 470.19 | 442.1 | 343.1 | |
Revenue Growth | 168.06% | 60.15% | 74.49% | 6.35% | 28.85% | 4.70% |
Cost of Revenue | 1,786 | 1,165 | 663.35 | 401.03 | 349.4 | 258.8 |
Gross Profit | 210.59 | 149.2 | 157.07 | 69.17 | 92.7 | 84.3 |
Selling, General & Admin | 11.62 | 11.87 | 12.62 | 9.16 | 18.6 | 15.6 |
Other Operating Expenses | 42.85 | 20.17 | 62.46 | 9.48 | 21.4 | 9.3 |
Operating Expenses | 66.29 | 42.79 | 85.01 | 23.06 | 44 | 27.3 |
Operating Income | 144.29 | 106.4 | 72.07 | 46.11 | 48.7 | 57 |
Interest Expense | -22.59 | -19.69 | -9.93 | -7.43 | -13.2 | -20.5 |
Interest & Investment Income | 0.26 | 0.26 | 0.08 | 0.26 | - | 1 |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.4 |
Other Non Operating Income (Expenses) | -0.98 | -0.98 | -0.86 | -1.01 | 1.7 | - |
Pretax Income | 120.98 | 85.99 | 61.35 | 37.93 | 37.2 | 37.9 |
Income Tax Expense | 30.77 | 21.98 | 19.78 | 4.92 | 9.1 | 9.9 |
Net Income | 90.21 | 64.01 | 41.58 | 33 | 28.1 | 28 |
Net Income to Common | 90.21 | 64.01 | 41.58 | 33 | 28.1 | 28 |
Net Income Growth | 156.54% | 53.95% | 25.98% | 17.45% | 0.36% | 400.00% |
Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 29 | 20 |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 29 | 20 |
Shares Change | -25.06% | - | 0.00% | 13.37% | 42.40% | 11.93% |
EPS (Basic) | 2.74 | 1.94 | 1.26 | 1.00 | 0.97 | 1.37 |
EPS (Diluted) | 2.74 | 1.94 | 1.26 | 1.00 | 0.97 | 1.37 |
EPS Growth | 242.45% | 53.97% | 26.00% | 3.57% | -29.52% | 346.69% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -94.49 | -77.09 | -39.52 | 22.95 | -90.5 | 6.3 |
Free Cash Flow Per Share | -2.87 | -2.34 | -1.20 | 0.70 | -3.11 | 0.31 |
Dividend Per Share | - | - | - | 0.083 | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 10.55% | 11.36% | 19.14% | 14.71% | 20.97% | 24.57% |
Operating Margin | 7.23% | 8.10% | 8.78% | 9.81% | 11.02% | 16.61% |
Profit Margin | 4.52% | 4.87% | 5.07% | 7.02% | 6.36% | 8.16% |
Free Cash Flow Margin | -4.73% | -5.87% | -4.82% | 4.88% | -20.47% | 1.84% |
EBITDA | 155.77 | 116.81 | 81.65 | 50.19 | 53 | 60.7 |
EBITDA Margin | 7.80% | 8.89% | 9.95% | 10.67% | 11.99% | 17.69% |
D&A For EBITDA | 11.48 | 10.41 | 9.58 | 4.08 | 4.3 | 3.7 |
EBIT | 144.29 | 106.4 | 72.07 | 46.11 | 48.7 | 57 |
EBIT Margin | 7.23% | 8.10% | 8.78% | 9.81% | 11.02% | 16.61% |
Effective Tax Rate | 25.43% | 25.56% | 32.23% | 12.98% | 24.46% | 26.12% |
Revenue as Reported | 1,997 | 1,315 | 820.52 | 470.61 | 444.7 | 344.8 |
Advertising Expenses | - | 0.71 | 2.51 | 0.01 | - | - |